Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on Cardinal Health (CAH – Research Report). The associated price target was ...

Cardinal's pharmaceutical and specialty solutions segment distributes branded, generic, and specialty drugs and over-the-counter healthcare and consumer products. Cardinal plays a central role in the ...

Management raised fiscal 2025 EPS guidance to $7.85-$8, a $0.10 increase at the midpoint, reflecting strong Pharma performance and contributions from recent acquisitions. The company expects Q3 to be ...

Cardinal Health warned Thursday that if President Donald Trump follows through with threatened tariffs next month, higher ...

Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.

Cardinal expects full-year earnings to be $7.85 to $8 per share. Cardinal shares have climbed 8% since the beginning of the year, while the S&P's 500 index has climbed 27%. The stock has risen 20% in ...

Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In ...

Stocks to Buy or Sell. In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE:CAH) stands against ...

India’s most prominent cardinal is standing down as Archbishop of Bombay, have reached the ago of 80 right before last ...

The Cape Girardeau County Commission approved contracts for juvenile detention services with Stoddard County and inmate health care with Cardinal Correctional Care, among other issues at Thursday's ...

27,587 people played the daily Crossword recently. Can you solve it faster than others?27,587 people played the daily Crossword recently. Can you solve it faster than others?